Fresenius Medical Care AG (FMCQF) Cost of Revenue (2009 - 2025)

Fresenius Medical Care AG (FMCQF) has reported Cost of Revenue for 17 consecutive years, with $4.3 billion the latest figure, recorded in Q4 2025.

• In Q4 2025, Cost of Revenue rose 5.13% year-over-year to $4.3 billion; the TTM figure through Dec 2025 stood at $13.5 billion (up 32.45% YoY), while the FY2025 annual figure was $17.0 billion, up 9.08% from the prior year.
• Cost of Revenue came in at $4.3 billion for Q4 2025 at Fresenius Medical Care AG, up from $1.3 billion in the prior quarter.
• The five-year high for Cost of Revenue was $4.3 billion in Q4 2025, with the low at $1.1 billion in Q2 2024.
• Average Cost of Revenue over 5 years is $3.5 billion, with a median of $3.8 billion recorded in 2023.
• Across the five-year window, Cost of Revenue slumped 71.76% in 2024 and surged 260.04% in 2025, its largest moves.
• Year by year, Cost of Revenue stood at $3.8 billion in 2021, then declined by 2.21% to $3.7 billion in 2022, then grew by 5.14% to $3.9 billion in 2023, then advanced by 4.12% to $4.1 billion in 2024, then increased by 5.13% to $4.3 billion in 2025.
• According to Business Quant data, Cost of Revenue over the past three periods registered $4.3 billion, $1.3 billion, and $4.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.